University Medical Center Groningen, Department of Radiology, Medical Imaging Center, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.
Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, Nijenborgh 4, 9747 AG Groningen, The Netherlands.
J Am Chem Soc. 2021 Jan 27;143(3):1513-1520. doi: 10.1021/jacs.0c11336. Epub 2021 Jan 15.
Photopharmacology addresses the challenge of drug selectivity and side effects through creation of photoresponsive molecules activated with light with high spatiotemporal precision. This is achieved through incorporation of molecular photoswitches and photocages into the pharmacophore. However, the structural basis for the light-induced modulation of inhibitory potency in general is still missing, which poses a major design challenge for this emerging field of research. Here we solved crystal structures of the glutamate transporter homologue Glt in complex with photoresponsive transport inhibitors-azobenzene derivative of TBOA (both in and configuration) and with the photocaged compound ONB-hydroxyaspartate. The essential role of glutamate transporters in the functioning of the central nervous system renders them potential therapeutic targets in the treatment of neurodegenerative diseases. The obtained structures provide a clear structural insight into the origins of photocontrol in photopharmacology and lay the foundation for application of photocontrolled ligands to study the transporter dynamics by using time-resolved X-ray crystallography.
光药理学通过用光激活的光响应分子来解决药物选择性和副作用的挑战,具有高精度的时空特异性。这是通过将分子光开关和光笼合入药效团来实现的。然而,对于一般的光诱导抑制效力调节的结构基础仍然缺失,这对这个新兴的研究领域构成了重大的设计挑战。在这里,我们解决了谷氨酸转运蛋白同源物 Glt 与光响应转运抑制剂-均三嗪衍生物 TBOA([ ]和[ ]构象)以及光笼合化合物 ONB-羟基天冬氨酸复合物的晶体结构。谷氨酸转运体在中枢神经系统功能中的重要作用使它们成为治疗神经退行性疾病的潜在治疗靶点。获得的结构为光药理学中的光控起源提供了明确的结构见解,并为应用光控配体通过时间分辨 X 射线晶体学研究转运体动力学奠定了基础。